China Healthcare Weekly (July.28)- Ascentage Gets "A Big Gift", CR Boya Acquires Green Cross, Weigao
We noticed some positive updates about Ascentage as competitors' products encountered challenges. China Resources Boya acquires Green Cross....
657 Views
Ascentage Pharma (6855.HK) Signs $1.3B Deal with Takeda - Finally on the Right Path
​Cooperation with Takeda saves Ascentage from survival problem, but self-building sales team remains a challenge. Investors eye anther deal with...
428 Views
[Blue Lotus Healthcare Sector Update]: Bottom-Fishing at the Bottom of the Business Cycle
​Liquidity crises in healthcare innovation present buying opportunity;PD-1 exceeds expectations with 20%YoY growth forecast for 2024;Biosimilars...
405 Views
Hong Kong Connect Flows Monthly: Health Care Led Inflows in Jan
We analyzed the Hong Kong Connect Scheme for January and highlight flows for China Mobile, BYD, Simcere, ICBC, CNOOC, Meituan, Geely, CCB, Country...
596 Views
ECM Weekly (20th Jan 23) - HK Brokers, Wuxi, IQIYI, Anycol, Adani, WM Mot, LG Ene, AIn, Oasis, Perta
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
753 Views